BIIB - Biogen Eisai launch Alzheimer's drug Leqembi in China
2024-06-28 06:17:57 ET
Biogen ( NASDAQ: BIIB ) and its Japanese partner Eisai’s ( OTCPK:ESALF ) ( OTCPK:ESAIY ) breakthrough Alzheimer's therapy, Leqembi (lecanemab), is now available in China, the companies announced late Thursday....
Biogen, Eisai launch Alzheimer's drug Leqembi in China